WO2012161545A3 - 엡스타인바 바이러스 마이크로 알엔에이를 포함하는 세포사멸 촉진 또는 세포성장억제를 위한 조성물 - Google Patents
엡스타인바 바이러스 마이크로 알엔에이를 포함하는 세포사멸 촉진 또는 세포성장억제를 위한 조성물 Download PDFInfo
- Publication number
- WO2012161545A3 WO2012161545A3 PCT/KR2012/004149 KR2012004149W WO2012161545A3 WO 2012161545 A3 WO2012161545 A3 WO 2012161545A3 KR 2012004149 W KR2012004149 W KR 2012004149W WO 2012161545 A3 WO2012161545 A3 WO 2012161545A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mir
- epstein
- cell growth
- barr virus
- inhibiting cell
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
- C12N2310/141—MicroRNAs, miRNAs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
본 발명은 엡스타인바바이러스 (Epstein-Barr virus : EBV) 의 miRNA, 특히 miR-BART4-5p, miR-BART4-3p, miR-BART1-5p, miR-BART15-3p, miR-BART5-5p, miR-BART5-3p, miR-BART16-5p, miR-BART16-3p, miR-BART17-3p, miR-BART21-3p, miR-BART18-5p, miR-BART7-5p, miR-BART9-5p, miR-BART22-5p, miR-BART20-3p, miR-BART13-5p, miR-BART13-3p, miR-BART2-3p 및 이들의 모방체(mimic)의 세포사멸(apoptosis) 촉진 및 세포생장(cell growth) 억제 용도와 관련된 것이다.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/122,236 US9243247B2 (en) | 2011-05-25 | 2012-05-24 | Composition for promoting apoptosis or inhibiting cell growth, comprising epstein-barr virus microrna |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2011-0049812 | 2011-05-25 | ||
KR1020110049812A KR101308941B1 (ko) | 2011-05-25 | 2011-05-25 | 엡스타인바 바이러스 마이크로 알엔에이를 포함하는 세포사멸 촉진 또는 세포성장억제를 위한 조성물 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2012161545A2 WO2012161545A2 (ko) | 2012-11-29 |
WO2012161545A3 true WO2012161545A3 (ko) | 2013-03-21 |
WO2012161545A9 WO2012161545A9 (ko) | 2013-05-10 |
Family
ID=47217923
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2012/004149 WO2012161545A2 (ko) | 2011-05-25 | 2012-05-24 | 엡스타인바 바이러스 마이크로 알엔에이를 포함하는 세포사멸 촉진 또는 세포성장억제를 위한 조성물 |
Country Status (3)
Country | Link |
---|---|
US (1) | US9243247B2 (ko) |
KR (1) | KR101308941B1 (ko) |
WO (1) | WO2012161545A2 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109321655B (zh) * | 2018-05-17 | 2022-07-05 | 福建省肿瘤医院(福建省肿瘤研究所、福建省癌症防治中心) | Nkiras2基因调控区序列、调控序列及其在鼻咽癌中的应用 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105154586A (zh) * | 2015-07-17 | 2015-12-16 | 中南大学 | EB病毒编码的microRNA BART10的应用方法 |
CN105154446B (zh) * | 2015-07-17 | 2018-08-28 | 中南大学 | EB病毒编码的microRNA BART10反义寡核苷酸的应用方法 |
CN105288657B (zh) * | 2015-10-30 | 2018-08-24 | 中南大学 | EB病毒编码的microRNA BART6-3p在制备胃癌细胞抑制剂上的应用 |
CN105200155B (zh) * | 2015-10-30 | 2018-11-30 | 中南大学 | EB病毒编码的microRNA BART6-3p的应用 |
CN105267987B (zh) * | 2015-10-30 | 2018-03-23 | 中南大学 | 长链非编码rna基因loc553103在制备胃癌细胞抑制剂上的应用 |
CN105233304B (zh) * | 2015-10-30 | 2018-03-23 | 中南大学 | 长链非编码rna基因loc553103在制备鼻咽癌细胞抑制剂上的应用 |
CN105238882A (zh) * | 2015-10-30 | 2016-01-13 | 中南大学 | EB病毒编码的microRNA BART6-3p在制备鼻咽癌预后制剂上的应用 |
CN105288656B (zh) * | 2015-10-30 | 2018-08-24 | 中南大学 | EB病毒编码的microRNA BART6-3p在制备鼻咽癌细胞抑制剂上的应用 |
KR101985067B1 (ko) | 2017-01-18 | 2019-05-31 | 가톨릭대학교 산학협력단 | miR-BART1-3p 억제제를 유효성분으로 포함하는 암의 예방 또는 치료용 조성물 |
CN110079603A (zh) * | 2019-06-14 | 2019-08-02 | 福建省肿瘤医院(福建省肿瘤研究所、福建省癌症防治中心) | 一种鼻咽癌标志物的检测引物、探针及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100216139A1 (en) * | 2008-11-10 | 2010-08-26 | Battelle Memorial Institute | METHODS, COMPOSITIONS, AND DEVICES UTILIZING MicroRNA TO DETERMINE PHYSIOLOGICAL CONDITIONS |
US20110033841A1 (en) * | 2007-02-26 | 2011-02-10 | The Chinese University Of Hong Kong | Methods and kits for diagnosis, prognosis or monitoring of epstein-barr virus (ebv)-associated cancer |
-
2011
- 2011-05-25 KR KR1020110049812A patent/KR101308941B1/ko active IP Right Grant
-
2012
- 2012-05-24 US US14/122,236 patent/US9243247B2/en active Active
- 2012-05-24 WO PCT/KR2012/004149 patent/WO2012161545A2/ko active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110033841A1 (en) * | 2007-02-26 | 2011-02-10 | The Chinese University Of Hong Kong | Methods and kits for diagnosis, prognosis or monitoring of epstein-barr virus (ebv)-associated cancer |
US20100216139A1 (en) * | 2008-11-10 | 2010-08-26 | Battelle Memorial Institute | METHODS, COMPOSITIONS, AND DEVICES UTILIZING MicroRNA TO DETERMINE PHYSIOLOGICAL CONDITIONS |
Non-Patent Citations (2)
Title |
---|
ELIZABETH YEE-WAI ET AL.: "An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival", J. EXP. MED., vol. 205, no. 11, 2008, pages 2551 - 2560 * |
ERI SETO ET AL.: "Micro RNAs of Epstein-Barr Virus Promote Cell Cycle Progression and Prevent Apoptosis of Primary Human B Cells", PIOS PATHOGENS, vol. 6, no. 8, August 2010 (2010-08-01), pages E1001063, 1-16 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109321655B (zh) * | 2018-05-17 | 2022-07-05 | 福建省肿瘤医院(福建省肿瘤研究所、福建省癌症防治中心) | Nkiras2基因调控区序列、调控序列及其在鼻咽癌中的应用 |
Also Published As
Publication number | Publication date |
---|---|
KR20120131557A (ko) | 2012-12-05 |
WO2012161545A9 (ko) | 2013-05-10 |
KR101308941B1 (ko) | 2013-09-24 |
US9243247B2 (en) | 2016-01-26 |
US20140296319A1 (en) | 2014-10-02 |
WO2012161545A2 (ko) | 2012-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012161545A3 (ko) | 엡스타인바 바이러스 마이크로 알엔에이를 포함하는 세포사멸 촉진 또는 세포성장억제를 위한 조성물 | |
IL284578A (en) | Double-stranded RNA suppressors of the hepatitis B virus, preparations containing them and their uses | |
WO2013049352A3 (en) | Anti-viral compounds | |
HK1207119A1 (zh) | 用於序列操縱的改進的系統、方法和酶組合物的工程和優化 | |
WO2011133722A3 (en) | Anti-viral compounds | |
WO2014028429A3 (en) | Enzymes and polymerases for the synthesis of rna | |
WO2011109279A9 (en) | Methods for purifying cells derived from pluripotent stem cells | |
EP4269584A3 (en) | Selective antisense compounds and uses thereof | |
WO2011133728A3 (en) | Anti-viral compounds | |
DK2791367T3 (da) | Mutante mikroorganismer til syntetisering af colansyre, mannosylerede og/eller fucosylerede oligosaccharider | |
IL227426A0 (en) | A system, method and object to encourage behavior change | |
WO2011133729A3 (en) | Anti-viral compounds | |
WO2012149058A3 (en) | Methods and system for interfering with viability of bacteria and related compounds and compositions | |
EP2622090A4 (en) | METHODS AND COMPOSITIONS FOR INHIBITING VIRUS INTAKE IN CELLS | |
WO2012024573A3 (en) | Compositions comrpising perivascular stem cells and nell-1 protein | |
WO2014206419A3 (en) | Compositions comprising fermented seaweed and/or algae | |
WO2014015210A3 (en) | Microorganisms and processes for the conversion of glycerol to isoprene | |
EP2729464B8 (en) | Cyclopropyl-fused-1,3-thiazepines as bace 1 and/or bace 2 inhibitors | |
ZA201208135B (en) | Systems, methods and composition relating to combustible biomaterials | |
WO2011133727A3 (en) | Anti-viral compounds | |
ZA201304509B (en) | Water clarification composition and process | |
WO2013049407A3 (en) | Anti-viral compounds | |
WO2012020108A3 (en) | Multimeric inhibitors of viral fusion and uses thereof | |
WO2011133707A3 (en) | Anti-viral compounds | |
EP2931746A4 (en) | METHOD AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF CKAP5 BY DOUBLE-STRUCTURED RNA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12790377 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14122236 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12790377 Country of ref document: EP Kind code of ref document: A2 |